Table 2 |
||||||
|
Host susceptibility genes identified by GWAS studies |
||||||
|
Pathogen |
Phenotype |
Gene |
N cases/controls |
Effect size |
P-value |
References |
|
|
||||||
|
Dengue virus |
Severe dengue |
MICB |
3, 742/4, 952 |
1.34 |
4.41 × 10-11 |
[20] |
|
Severe dengue |
PLCE1 |
3, 742/4, 952 |
0.80 |
3.08 × 10-10 |
[20] |
|
|
N. meningitidisa |
Meningococcal disease |
CFH |
1, 443/6, 079 |
0.64 |
2.2 × 10-11 |
[7] |
|
P. falciparuma |
Severe malaria |
ABO |
3, 906/5, 489 |
1.20 |
2.0 × 10-7 |
|
|
Severe malaria |
HBB |
2, 045/3, 758 |
0.63 |
3.7 × 10-11 |
[62] |
|
|
M. leprae |
Leprosy |
NOD2 |
3, 960/7, 180 |
1.59 |
3.77 × 10-40 |
[5] |
|
RIPK2 |
3, 960/7, 180 |
0.76 |
1.38 × 10-16 |
[5] |
||
|
HLA-DR |
3, 960/7, 180 |
0.67 |
5.35 × 10-27 |
[5] |
||
|
TNFSF15 |
3, 960/7, 180 |
1.37 |
3.39 × 10-21 |
[5] |
||
|
C13orf31-CCDC122 |
3, 960/7, 180 |
1.68 |
3.72 × 10-54 |
[5] |
||
|
M. tuberculosis |
Tuberculosis |
- |
3, 632/7, 501 |
1.19 |
6.8 × 10-9 |
[63] |
|
HIV |
Viral set pointa |
HLA-B |
486 |
9.6% |
9.36 × 10-12 |
[6] |
|
Viral set pointa |
HLA-C |
486 |
6.5% |
3.77 × 10-9 |
[6] |
|
|
HBV |
Chronic infection |
HLA-DP |
2, 086/4, 301 |
1.75 |
6.34 × 10-39 |
|
|
|
||||||
|
aAnalyzed as a quantitative trait. |
||||||
|
Khor and Hibberd Genome Biology 2011 12:229 doi:10.1186/gb-2011-12-10-229 |
||||||